MENU
+Compare
GRX
ETF ticker: NYSE
AS OF
Dec 24 closing price
Price
$9.62
Change
-$0.06 (-0.62%)
Net Assets
164.83M

GRX stock forecast, quote, news & analysis

Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company... Show more

GRX
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for GRX with price predictions
Dec 24, 2025

GRX in -1.06% downward trend, sliding for three consecutive days on December 17, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where GRX declined for three days, in of 280 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for GRX moved out of overbought territory on December 12, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GRX as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where GRX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GRX just turned positive on December 24, 2025. Looking at past instances where GRX's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

GRX moved above its 50-day moving average on December 18, 2025 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for GRX moved above the 200-day moving average on December 01, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GRX advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .

GRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 255 cases where GRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Industry description

Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.

Volume

The average weekly volume growth across all stocks in the Gabelli Healthcare & Wellness Trust (The) ETF was -72%. For the same stocks of the ETF, the average monthly volume growth was -83% and the average quarterly volume growth was -85%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 35
Price Growth Rating: 45
SMR Rating: 58
Profit Risk Rating: 50
Seasonality Score: 24 (-100 ... +100)
View a ticker or compare two or three
GRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Unknown

Profile
Fundamentals
Details
Category
Health
Address
One Corporate CenterRye
Phone
N/A
Web
N/A